Nathaniel Harder

Mr. Nathaniel Harder

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2019 in Metallomics
Verified
Journal Article
Open access
PDF file
MSMichael J. Stevenson
Michael J. Stevenson
KUKylie S. Uyeda
Kylie S. Uyeda
NHNathaniel Harder
Nathaniel Harder
MHMarie C. Heffern
Marie C. Heffern
Advances in understanding of hormones and metal micronutrients show critical interactions between the two in a newly-termed field of metalloendocrinology.

25 August 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
NHNathaniel Harder
Nathaniel Harder
Bettina HieronimusBettina Hieronimus
Bettina Hieronimus
Kimber L. StanhopeKimber L. Stanhope
Kimber L. Stanhope
NSNoreene M. Shibata
Noreene M. Shibata
VLVivien Lee
Vivien Lee
VMValentina Medici
Valentina Medici
Alterations of transition metal levels have been associated with obesity, hepatic steatosis, and metabolic syndrome in humans. Studies in animals indicate an association between dietary sugars and copper metabolism. Our group has conducted a study in which young adults consumed beverages sweetened with glucose, fructose, high fructose corn syrup (HFCS), or aspartame for two weeks and has reported that consumption of both fructose- and HFCS-sweetened beverages increased cardiovascular disease risk factors. Baseline and intervention serum samples from 107 participants of this study were measured for copper metabolism (copper, ceruloplasmin ferroxidase activity, ceruloplasmin protein), zinc levels, and iron metabolism (iron, ferritin, and transferrin) parameters. Fructose and/or glucose consumption were associated with decreased ceruloplasmin ferroxidase activity and serum copper and zinc concentrations. Ceruloplasmin protein levels did not change in response to intervention. The changes in copper concentrations were correlated with zinc, but not with iron. The decreases in copper, ceruloplasmin ferroxidase activity, ferritin, and transferrin were inversely associated with the increases in metabolic risk factors associated with sugar consumption, specifically, apolipoprotein CIII, triglycerides, or post-meal glucose, insulin, and lactate responses. These findings are the first evidence that consumption of sugar-sweetened beverages can alter clinical parameters of transition metal metabolism in healthy subjects.

17 March 2020 in Science Signaling
Verified
Journal Article
Closed access
PDF file
SYShen Yang
Shen Yang
MSMattias N. D. Svensson
Mattias N. D. Svensson
NHNathaniel Harder
Nathaniel Harder
WHWan-Chen Hsieh
Wan-Chen Hsieh
ESEugenio Santelli
Eugenio Santelli
NBNunzio Bottini
Nunzio Bottini
Phosphorylation of PTPN22 at Ser 751 balances phosphatase degradation and plasma membrane recruitment.

11 September 2023 in Hepatology Communications
Verified
Journal Article
Open access
GSGaurav Sarode
Gaurav Sarode
TMTagreed Mazi
Tagreed Mazi
KNKari Neier
Kari Neier
NSNoreene M. Shibata
Noreene M. Shibata
GJGuillaume Jospin
Guillaume Jospin
VMValentina Medici
Valentina Medici
Background: The clinical manifestations of Wilson disease (WD) are related to copper accumulation in the liver and the brain, but little is known about other tissue involvement regarding metabolic changes in WD. In vitro studies suggested that the loss of intestinal ATP7B affects metabolic dysregulation in WD. We tested this hypothesis by evaluating the gut microbiota and lipidome in 2 mouse models of WD and by characterizing a new mouse model with a targeted deletion of Atp7b in the intestine. Methods: Cecal content 16S sequencing and untargeted hepatic and plasma lipidome analyses in the Jackson Laboratory toxic-milk and the Atp7b null global knockout mouse models of WD were profiled and integrated. Intestine-specific Atp7b knockout mice (Atp7b ΔIEC) were generated and characterized using targeted lipidome analysis following a high-fat diet challenge. Results: Gut microbiota diversity was reduced in animal models of WD. Comparative prediction analysis revealed amino acid, carbohydrate, and lipid metabolism functions to be dysregulated in the WD gut microbial metagenome. Liver and plasma lipidomic profiles showed dysregulated triglyceride and diglyceride, phospholipid, and sphingolipid metabolism in WD models. However, Atp7b ΔIEC mice did not show gut microbiome differences compared to wild type. When challenged with a high-fat diet, Atp7b ΔIEC mice exhibited profound alterations to fatty acid desaturation and sphingolipid metabolism pathways as well as altered APOB48 distribution in intestinal epithelial cells. Conclusions: Gut microbiome and lipidome underlie systemic metabolic manifestations in murine WD. Intestine-specific ATP7B deficiency affected both intestinal and systemic response to a high-fat challenge but not the microbiome profile, at least at early stages. WD is a systemic disease in which intestinal-specific ATP7B loss and diet influence the phenotype and the lipidome profile.

10 August 2020 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
PDF file
JOJustin J. O’sUllivan
Justin J. O’sUllivan
NHNathaniel Harder
Nathaniel Harder
MHMarie C. Heffern
Marie C. Heffern

20 March 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ACAmanda Caceres
Amanda Caceres
NHNathaniel Harder
Nathaniel Harder
JPJacob P. Padilla
Jacob P. Padilla
SJSamuel E. Janisse
Samuel E. Janisse
ACAustin M. Cole
Austin M. Cole
MHMarie C. Heffern
Marie C. Heffern
Iron is an essential biometal, critical in processes that include oxygen transport, mitochondrial respiration, and cell signaling. Iron dyshomeostasis is linked with hyperglycemia and associated metabolic disorders, but the underlying mechanisms are poorly understood. To investigate these mechanisms, we conducted a short-term, four-week, in vivo study on mice given water supplemented with glucose. The short time frame was sufficient to cause metabolic shifts in the liver towards triglyceride synthesis. We sought to comprehensively track iron trafficking by analyzing liver and serum markers of iron metabolism alongside LC-ICP-MS analysis of iron speciation, which is a new approach in this context. Glucose supplementation induced changes in iron regulation despite equal dietary iron intake between groups. Specifically, we observed increased uptake of transferrin-bound iron from the serum and an iron overload state in the liver. We developed and applied a cell-based models of this glucose-induced iron overload state and found that, on the one hand, the anti-diabetic drug metformin could restore iron regulation; on the other hand, the iron chelator, deferoxamine, could restore glucose metabolism. Taken together, our studies reveal that early hyperglycemia is sufficient to cause disruptions in iron regulations, pointing to iron overload as viable therapeutic target in metabolic dysfunction.